Metagenomic next-generation sequencing aids the diagnosis of viral infections in febrile returning travellers.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
10 2019
Historique:
received: 08 05 2019
revised: 18 07 2019
accepted: 03 08 2019
pubmed: 10 8 2019
medline: 25 7 2020
entrez: 10 8 2019
Statut: ppublish

Résumé

Travel-associated infections are challenging to diagnose because of the broad spectrum of potential aetiologies. As a proof-of-principle study, we used MNGS to identify viral pathogens in clinical samples from returning travellers in a single center to explore its suitability as a diagnostic tool. Plasma samples from 40 returning travellers presenting with a fever of ≥38°C were sequenced using MNGS on the Illumina MiSeq platform and compared with standard-of-care diagnostic assays. In total, 11/40 patients were diagnosed with a viral infection. Standard of care diagnostics revealed 5 viral infections using plasma samples; dengue virus 1 (n = 2), hepatitis E (n = 1), Ebola virus (n = 1) and hepatitis A (n = 1), all of which were detected by MNGS. Three additional patients with Chikungunya virus (n = 2) and mumps virus were diagnosed by MNGS only. Respiratory infections detected by nasal/throat swabs only were not detected by MNGS of plasma. One patient had infection with malaria and mumps virus during the same admission. MNGS analysis of plasma samples improves the sensitivity of diagnosis of viral infections and has potential as an all-in-one diagnostic test. It can be used to identify infections that have not been considered by the treating physician, co-infections and new or emerging pathogens. Next generation sequencing (NGS) has potential as an all-in-one diagnostic test. In this study we used NGS to diagnose returning travellers with acute febrile illness in the UK, highlighting cases where the diagnosis was missed using standard methods.

Identifiants

pubmed: 31398374
pii: S0163-4453(19)30242-7
doi: 10.1016/j.jinf.2019.08.003
pmc: PMC6859916
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

383-388

Subventions

Organisme : Medical Research Council
ID : MC_UU_12014/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12014/12
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 102789/Z/13/A
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Clin Infect Dis. 2015 Mar 15;60(6):881-8
pubmed: 25572899
Parasitology. 2014 Dec;141(14):1856-62
pubmed: 24576467
J Mol Diagn. 2008 May;10(3):185-97
pubmed: 18403608
PLoS One. 2010 Oct 18;5(10):e13381
pubmed: 20976137
PLoS Pathog. 2008 Nov;4(11):e1000212
pubmed: 19023410
J Clin Microbiol. 2016 Oct;54(10):2470-84
pubmed: 27385709
Emerg Infect Dis. 2014 Jun;20(6):1072-5
pubmed: 24857411
N Engl J Med. 2019 Jun 13;380(24):2327-2340
pubmed: 31189036
PLoS Pathog. 2009 May;5(5):e1000455
pubmed: 19478873
J Comput Biol. 2015 Jun;22(6):528-45
pubmed: 25734602
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
Nat Rev Genet. 2016 May 17;17(6):333-51
pubmed: 27184599
Lancet Infect Dis. 2015 Jan;15(1):55-64
pubmed: 25477022
PLoS Pathog. 2012 Sep;8(9):e1002924
pubmed: 23028323
J Infect Dis. 2008 Jan 15;197(2):183-6
pubmed: 18179384
Genome Med. 2015 Sep 29;7:99
pubmed: 26416663
Nat Med. 2019 Jun;25(6):909-910
pubmed: 31160814
BMC Bioinformatics. 2011 Sep 30;12:385
pubmed: 21961884
N Engl J Med. 2015 Jul 9;373(2):154-62
pubmed: 26154788
BMC Genomics. 2014 Feb 04;15:96
pubmed: 24495417
Clin Infect Dis. 2019 Jan 7;68(2):330-333
pubmed: 29961823
Nature. 2016 Feb 11;530(7589):228-232
pubmed: 26840485
Nat Rev Genet. 2019 Jun;20(6):341-355
pubmed: 30918369
Nat Methods. 2015 Jan;12(1):59-60
pubmed: 25402007
Transpl Infect Dis. 2016 Dec;18(6):960-964
pubmed: 27632248
J Appl Genet. 2013 Aug;54(3):309-25
pubmed: 23553074
JAMA. 2013 Apr 10;309(14):1502-10
pubmed: 23571589
N Engl J Med. 2014 Jun 19;370(25):2408-17
pubmed: 24896819
J Comput Biol. 2013 Oct;20(10):714-37
pubmed: 24093227
Bioinformatics. 2011 Mar 15;27(6):863-4
pubmed: 21278185
PLoS Negl Trop Dis. 2011 Sep;5(9):e1304
pubmed: 21909446
Clin Infect Dis. 2015 Mar 15;60(6):919-23
pubmed: 25572898
Lancet. 2016 Jul 30;388(10043):498-503
pubmed: 27209148
Curr Opin Ophthalmol. 2016 Nov;27(6):561-567
pubmed: 27585214

Auteurs

Hanna Jerome (H)

MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, 464 Bearsden Road, Glasgow G61 1QH, UK.

Callum Taylor (C)

Department of Infectious Diseases, Queen Elizabeth University Hospital, 1345 Govan Rd, Govan, Glasgow G51 4TF, UK.

Vattipally B Sreenu (VB)

MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, 464 Bearsden Road, Glasgow G61 1QH, UK.

Tanya Klymenko (T)

MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, 464 Bearsden Road, Glasgow G61 1QH, UK.

Ana Da Silva Filipe (ADS)

MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, 464 Bearsden Road, Glasgow G61 1QH, UK.

Celia Jackson (C)

West of Scotland Specialist Virology Centre, Level 5, New Lister Building, Glasgow Royal Infirmary, 10-16 Alexandra Parade, Glasgow G31 2ER, UK.

Chris Davis (C)

MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, 464 Bearsden Road, Glasgow G61 1QH, UK.

Shirin Ashraf (S)

MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, 464 Bearsden Road, Glasgow G61 1QH, UK.

Eleri Wilson-Davies (E)

West of Scotland Specialist Virology Centre, Level 5, New Lister Building, Glasgow Royal Infirmary, 10-16 Alexandra Parade, Glasgow G31 2ER, UK.

Natasha Jesudason (N)

Queen Elizabeth University Hospital, 1345 Govan Rd, Govan, Glasgow G51 4TF, UK.

Karen Devine (K)

Department of Infectious Diseases, Queen Elizabeth University Hospital, 1345 Govan Rd, Govan, Glasgow G51 4TF, UK.

Lisbeth Harder (L)

MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, 464 Bearsden Road, Glasgow G61 1QH, UK.

Celia Aitken (C)

West of Scotland Specialist Virology Centre, Level 5, New Lister Building, Glasgow Royal Infirmary, 10-16 Alexandra Parade, Glasgow G31 2ER, UK.

Rory Gunson (R)

West of Scotland Specialist Virology Centre, Level 5, New Lister Building, Glasgow Royal Infirmary, 10-16 Alexandra Parade, Glasgow G31 2ER, UK.

Emma C Thomson (EC)

MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, 464 Bearsden Road, Glasgow G61 1QH, UK; Department of Infectious Diseases, Queen Elizabeth University Hospital, 1345 Govan Rd, Govan, Glasgow G51 4TF, UK. Electronic address: emma.thomson@glasgow.ac.uk.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH